Erich Rajkovic
Chief Business Officer Stealth Stage Company
Seminars
Wednesday 9th December 2026
Showcasing Clinical Progress in Complement-Mediated Kidney Diseases & Generating Evidence to Advance Patient Care
9:00 am
- Presenting key efficacy, safety and biomarker findings from a clinical complement therapy program in kidney disease
- Evaluating treatment response across patient populations and assessing how disease biology influences clinical outcomes
- Sharing learnings from trial execution, endpoint selection and patient monitoring to inform future kidney disease development programs
NEW SPEAKING COMPANY
